MedTrace Logo

Benefits of Pulmonary Rehabilitation to Patients Post Liver Transplant

NCT06606184 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 78

Last updated 2024-09-20

No results posted yet for this study

Summary

The goal of this clinical trial was to access the benefits of a 12-week home-based pulmonary rehabilitation regimen on pulmonary function recovery in post-liver transplant patients. The main questions it aims to answer are:

Does pulmonary rehabilitation facilitate pulmonary muscle strength recovery? Does the intervention improve pulmonary function and reduce dyspnea sensation?

Participants performed:

Inspiratory muscle training twice a day for 12 weeks after discharged from the hospital Upper limb resistive training Lower limb exercise

Conditions

  • Liver Transplant Surgery

Interventions

PROCEDURE

Inspiratory muscle Training

Participants underwent a 12-week program consisting of inspiratory muscle training twice daily, incentive spirometry three times daily, and upper limb exercises along with marching in place for 30 minutes.

PROCEDURE

Routine Care

Participants received routine care, which included encouragement to use incentive spirometry three times daily.

Sponsors & Collaborators

  • Chang Gung University of Science and Technology

    collaborator OTHER

  • Chang Gung Memorial Hospital

    collaborator OTHER

  • Chang Gung University

    lead OTHER

Principal Investigators

  • Jui-Fang Lin, PhD · Chang Gung University of Science and Technology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06606184 on ClinicalTrials.gov